Articles

Any way you slice it, the odds are against QS stock right now. Staying away continues to be your best move. More

Pharma stocks can be a great investment, particularly if they have solid performance, revenue growth and a positive outlook. More

Higher interest rates, a banking crisis and scandals made these the best bank stocks trading at attractive multiples. More

In light of delivery growth uncertainty and falling margins, there's a clear takeaway: NIO stock is still a sell. More

SPY stock offers diversification, but not as much as you probably think. So, consider an alternative ETF that too many investors are ignoring. More

PYPL stock is down but definitely not out as PayPal's CEO succession plan keeps investors guessing about the company's future direction. More

Carvana is getting proactive in reducing its debt load, so don't treat CVNA stock as a trivial short-squeeze candidate. More

Subscriber Sign in